Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Bone Diseases, Metabolic 3Prostatic Neoplasms 2Osteoporosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Esophageal Neoplasms 1Dwarfism, Pituitary 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Zoledronic Acid 8Letrozole 4Vitamin D 3Calcium 3Risedronic Acid 2Nutrition Assessment 2Denosumab 2Cholecalciferol 2Calcium Gluconate 2Calcium Carbonate 2Aromatase Inhibitors 2parathyroid hormone-related peptide (1-36) 1Technetium 1Resistance Training 1Radiotherapy 1Observation 1Kyphoplasty 1Ibandronic Acid 1Gonadotropin-Releasing Hormone 1Geritol 1Calcium Citrate 1Anastrozole 1Alendronate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Osteoporosis × Risedronic Acid × Clear all
NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
72 enrolled 8 charts
LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00485953 2017-10-13

REBBeCA II

University of Pittsburgh

Phase 4 Completed
109 enrolled 11 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡